Skip to page content

Guide for Aviation Medical Examiners

Decision Considerations Disease Protocols - Attention Deficit/Hyperactivity Disorder

Why is a neuropsychological evaluation required?
Attention-Deficit/Hyperactivity Disorder (ADHD), formerly called Attention Deficit Disorder (ADD), and medications used for treatment may result in cognitive deficits that would make an airman unsafe to perform pilot duties.

What testing is required?
There are two test batteries:

  1. INITIAL BATTERY - performed on everyone; and
  2. SUPPLEMENTAL BATTERY - performed when the Initial Battery indicates a potential problem.

Why is a CogScreen-Aeromedical Edition (CogScreen-AE) required?
CogScreen-AE is a neurocognitive test developed to assist the FAA in the evaluation of the domains of neurocognitive performance most important for safety of flight.

Who may perform a neuropsychological evaluation?
A licensed clinical psychologist with experience in Aerospace Neuropsychology who is either board-certified or board eligible in clinical neuropsychology. Board eligible for FAA purposes means that the clinical neuropsychologist has the education, training, and clinical practice experience that would qualify him or her to sit for board certification with either the American Board of Clinical Neuropsychology or the American Board of Professional Neuropsychology.

Specifications for Neuropsychological Evaluations for ADHD/ADD:

Page last modified:

This page was originally published at: